Estrogen Receptor Negative Recruiting Phase 2 Trials for Carboplatin (DB00958)

IndicationStatusPhase
DBCOND0036417 (Estrogen Receptor Negative)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02593175Women's MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBCTreatment
NCT02876107Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast CancerTreatment
NCT03213041Pembrolizumab and Carboplatin in Treating Patients With Circulating Tumor Cells Positive Metastatic Breast CancerTreatment